Publications
- 4- years results of weekly trastuzumab and paklitaxel in the treatment with women with HER2/neu overexpressing advanced breast cancor: singl prospective study2004 | First Faculty of Medicine
- Efficacy of weekly transtuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes2002 | First Faculty of Medicine
- Komentář k článku Onkologická bolest léčen á buprenorfinem v monoterapii2023 | Publication without faculty affiliation
- Léčba HER2-dependentního generalizovaného karcinomu prsu v 1. linii u mladé pacientky2018 | Publication without faculty affiliation
- Interesting cases of nutritional care in oncology2014 | First Faculty of Medicine
- Interesting cases of nutritional care in oncology +22013 | Publication without faculty affiliation
- Outcomes of patients with oesophageal cancer treated with preoperative chemoradiotherapy, followed by tumor resection: influence of nutritional factors2012 | First Faculty of Medicine
- Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up2010 | First Faculty of Medicine
- Neurotoxicity of mitotan as the main side effect in adrenal carcinoma treatment, importance of mitotan blood levels monitoring2008 | First Faculty of Medicine
- The analysis of NBS-1 gene mutation (657del(5)) in exon 6 in the population of 472 sporadic breast cancer patients the Czech republic2006 | First Faculty of Medicine
Loading network view...